Order Article Reprints

Abouzayed A, Rinne SS, Sabahnoo H, Sörensen J, Chernov V, Tolmachev V, Orlova A. Preclinical Evaluation of ^99mTc-Labeled GRPR Antagonists maSSS/SES-PEG₂-RM26 for Imaging of Prostate Cancer. Pharmaceutics. 2021; 13(2):182. https://doi.org/10.3390/pharmaceutics13020182

Abouzayed, Ayman, Sara S. Rinne, Hamideh Sabahnoo, Jens Sörensen, Vladimir Chernov, Vladimir Tolmachev, and Anna Orlova. 2021. "Preclinical Evaluation of ^99mTc-Labeled GRPR Antagonists maSSS/SES-PEG₂-RM26 for Imaging of Prostate Cancer" Pharmaceutics 13, no. 2: 182. https://doi.org/10.3390/pharmaceutics13020182

Abouzayed, A., Rinne, S. S., Sabahnoo, H., Sörensen, J., Chernov, V., Tolmachev, V., & Orlova, A. (2021). Preclinical Evaluation of ^99mTc-Labeled GRPR Antagonists maSSS/SES-PEG₂-RM26 for Imaging of Prostate Cancer. Pharmaceutics, 13(2), 182. https://doi.org/10.3390/pharmaceutics13020182